A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
Clinical trial NCT05556616 · TERMINATED
Trial details
- NCT number
- NCT05556616
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2024-06-04
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.